FDAFinal Rule

Medical Devices; Hematology and Pathology Devices; Classification of the Coagulation System for the Measurement of Whole Blood Viscoelastic Properties in Perioperative Patients

Healthcare

Summary

The FDA is establishing official guidelines for a medical device that measures how quickly blood clots during surgery, helping doctors make better decisions about blood transfusions and bleeding control. This classification makes it easier for manufacturers to bring these devices to market while ensuring they work safely and accurately.

Key Points

  • 1The regulation classifies a specific blood-clotting measurement device (coagulation system) as a Class II medical device, meaning it requires moderate oversight but not the most stringent approval process
  • 2The device measures viscoelastic properties of whole blood, which essentially means it tests how blood's thickness and ability to clot change during surgery in real-time
  • 3This classification applies specifically to perioperative patients—people undergoing surgical procedures—where quick blood clotting assessments can prevent dangerous bleeding complications
  • 4Manufacturers of these devices now have a clearer regulatory pathway and know what standards their products must meet to be approved and sold
  • 5Surgeons and anesthesiologists can more reliably use these devices to guide decisions about blood transfusions and blood-clotting medications during operations

Key Dates

Published

May 9, 2025

This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.

The Digest Network